z-logo
open-access-imgOpen Access
Complications of Coronavirus Disease-19 in a Hospitalized Patient: A Case Report
Author(s) -
Iskra Meshkova,
Dragan Mijakoski,
Magdalena Simeonova,
Zorica Markovska,
Vesna Markoska
Publication year - 2020
Publication title -
open access macedonian journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 17
ISSN - 1857-9655
DOI - 10.3889/oamjms.2020.5615
Subject(s) - medicine , azithromycin , continuous positive airway pressure , mechanical ventilation , ceftriaxone , anesthesia , pediatrics , antibiotics , obstructive sleep apnea , microbiology and biotechnology , biology
BACKGROUND: Coronavirus (CoV) disease (COVID)-19 infection is a major public health issue worldwide with no specific therapy or vaccine. CASE REPORT: COVID-19-positive patient was hospitalized due to a dry irritating cough that has persisted for 3 days. The polymerase chain reaction test to severe acute respiratory syndrome-CoV-2 was positive. Computed tomography (CT) scan of the lungs showed massive bilateral consolidation. The patient was set to oxygen support (6 L/min). Two hours after referring the patient’s condition worsened with shortness of breath, suffocation, wheezing, and decreased saturation (77%). The patient was given mechanical support with continuous positive airway pressure mask. Therapy included azithromycin 500 mg and ceftriaxone 2 g. On the 3rd day of hospitalization, there was a sharp deterioration of the condition and a decrease in saturation (40%). The patient was intubated and immediately placed on intermittent positive pressure ventilation. Azithromycin was now combined with meropenem 3 × 1 g. The next morning patient’s condition further worsened with decrease in saturation and heart rate. The resuscitation was unsuccessful. CONCLUSION: COVID-19 is primary a respiratory infection, but the virus also affects other organs with poor outcome.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here